Fluid Imaging Technologies Seeks Submissions for Research Grant
Fluid Imaging Technologies calls for submissions for its Life Sciences & Materials Research Grant.
Fluid Imaging Technologies announced a call for submissions for its Life Sciences & Materials Research Grant. Graduate students and senior undergraduates enrolled at a North American college or university who are studying biotechnology, biochemistry, material science/engineering, or related fields with an interest in micro-particle analysis are encouraged to apply for the use of a FlowCAM dynamic imaging particle analyzer to support their research.
The winner of the award will receive use of a FlowCAM for a period of up to four months, instrument training and on-going technical support, and a paid trip to an appropriate North American conference within 12 months of project completion to share the results of their work. Judging criteria will include scientific merit, appropriate use of the FlowCAM, and the ability to obtain measurable results during a research period of four months. Proposals are due May 16, 2014.
Source:Fluid Imaging Technologies
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
